B. Metzler seel. Sohn & Co. AG Increases Stock Holdings in GE HealthCare Technologies Inc. $GEHC

B. Metzler seel. Sohn & Co. AG grew its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 300.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 58,211 shares of the company’s stock after purchasing an additional 43,673 shares during the period. B. Metzler seel. Sohn & Co. AG’s holdings in GE HealthCare Technologies were worth $4,372,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in GEHC. Dodge & Cox lifted its holdings in GE HealthCare Technologies by 42.1% during the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after buying an additional 6,982,441 shares in the last quarter. Norges Bank acquired a new stake in shares of GE HealthCare Technologies in the second quarter valued at $468,120,000. Holocene Advisors LP boosted its holdings in GE HealthCare Technologies by 178.5% in the second quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock valued at $298,306,000 after purchasing an additional 2,581,522 shares during the period. Menora Mivtachim Holdings LTD. acquired a new position in GE HealthCare Technologies during the 2nd quarter worth $80,755,000. Finally, Balyasny Asset Management L.P. purchased a new stake in GE HealthCare Technologies during the 2nd quarter worth about $58,388,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 1.8%

Shares of GEHC stock opened at $75.63 on Tuesday. The company has a market capitalization of $34.47 billion, a P/E ratio of 16.59, a price-to-earnings-growth ratio of 1.63 and a beta of 1.03. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. The business’s 50 day moving average is $81.66 and its two-hundred day moving average is $78.62. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping the consensus estimate of $1.40 by $0.04. The company had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business’s revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the business earned $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

Analysts Set New Price Targets

GEHC has been the subject of several recent research reports. The Goldman Sachs Group reiterated a “buy” rating and issued a $98.00 price objective on shares of GE HealthCare Technologies in a research note on Friday, January 9th. BTIG Research lifted their price target on shares of GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a research note on Wednesday, February 4th. Wells Fargo & Company raised their price objective on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Morgan Stanley boosted their target price on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 4th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. Seven investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $92.50.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.